Advances in Therapy

3.6k papers and 58.6k indexed citations i.

About

The 3.6k papers published in Advances in Therapy in the last decades have received a total of 58.6k indexed citations. Papers published in Advances in Therapy usually cover Surgery (656 papers), Pulmonary and Respiratory Medicine (587 papers) and Endocrinology, Diabetes and Metabolism (512 papers) specifically the topics of Diabetes Treatment and Management (252 papers), Glaucoma and retinal disorders (158 papers) and Asthma and respiratory diseases (158 papers). The most active scholars publishing in Advances in Therapy are Alan D. Kaye, Joerg Gruenwald, Anastasios G. P. Konstas, Roger S. McIntyre and Alfio Ferlito.

In The Last Decade

Fields of papers published in Advances in Therapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Advances in Therapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Advances in Therapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Advances in Therapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Advances in Therapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025